发明名称 Derivado de imidazol, composição farmacêutica, métodos para a produção de um derivado de imidazol e de um composto oticamente ativo de um derivado de imidazol ou de um seu sal farmaceuticamente aceitável, composto, sal, e, sal diastereomérico
摘要 The present invention provides a compound having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumour such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula: wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.
申请公布号 BR0115306(B1) 申请公布日期 2013.12.24
申请号 BR20010115306 申请日期 2001.11.16
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 AKIHIRO TASAKA;TAKONORI HITAKA;NOBUYUKI MATSUNAGA;MASAMI KUSAKA;MARI ADACHI;ISAO AOKI;AKIO OJIDA
分类号 C07D233/62;C07D487/04;A61K31/165;A61K31/4174;A61K31/4188;A61K31/437;A61K45/00;A61P5/28;A61P35/00;A61P43/00;C07D233/54;C07D471/04 主分类号 C07D233/62
代理机构 代理人
主权项
地址